Table 2 The lipoprotein subfractions and their contents of lipids and lipoproteins in means and standard deviations (SD) by Nuclear Magnetic Resonance analyses

Total plasma, mg/dL

125 (57.2)

245 (58.9)

77.7 (17.8)

−

188 (36.7)

40.5 (9.53)

84.3 (23.1)

VLDL, mg/dL

70.1 (47.3)

16.4 (12.6)

8.81 (5.24)

18.9 (12.4)

−

−

5.29 (3.38)

 VLDL1, mg/dL

40.5 (20.4)

5.85 (4.05)

2.33 (1.53)

7.25 (4.99)

−

−

−

 VLDL2, mg/dL

11.6 (8.88)

2.94 (2.21)

0.96 (0.84)

3.77 (2.81)

−

−

−

 VLDL3, mg/dL

7.80 (7.36)

2.23 (2.40)

1.19 (0.88)

4.20 (3.02)

−

−

−

 VLDL4, mg/dL

6.14 (4.97)

3.01 (2.93)

1.34 (1.32)

4.18 (3.31)

−

−

−

 VLDL5, mg/dL

1.86 (0.84)

1.12 (0.33)

0.46 (0.25)

1.70 (1.09)

−

−

−

 VLDL6, mg/dL

3.65 (1.41)

0.15 (0.01)

0.02 (0.05)

0.40 (0.03)

−

−

−

ILDL, mg/dL

12.2 (7.23)

9.69 (5.65)

3.29 (1.64)

7.37 (3.44)

−

−

3.67 (1.52)

LDL, mg/dL

24.8 (5.99)

142 (45.5)

48.4 (13.6)

82.2 (23.1)

−

−

67.7 (19.8)

 LDL1, mg/dL

7.32 (2.77)

24.2 (7.92)

8.80 (2.82)

9.66 (4.33)

−

−

9.74 (2.86)

 LDL2, mg/dL

2.28 (0.77)

20.9 (8.44)

6.87 (2.94)

12.5 (4.71)

−

−

7.96 (3.08)

 LDL3, mg/dL

2.43 (0.86)

25.4 (9.08)

10.1 (2.95)

14.4 (4.85)

−

−

10.6 (3.44)

 LDL4, mg/dL

3.93 (1.24)

35.6 (11.6)

11.5 (3.14)

18.5 (6.43)

−

−

11.8 (3.16)

 LDL5, mg/dL

2.68 (1.36)

26.0 (10.4)

9.65 (2.98)

14.5 (5.52)

−

−

12.2 (4.85)

 LDL6, mg/dL

4.94 (1.59)

27.8 (12.1)

8.42 (3.34)

16.1 (6.20)

−

−

15.8 (6.49)

HDL, mg/dL

10.2 (4.60)

72.7 (19.4)

23.2 (5.56)

104 (25.3)

146 (32.5)

38.2 (8.74)

−

 HDL1, mg/dL

4.39 (2.69)

21.3 (12.0)

9.22 (3.63)

28.3 (14.6)

27.3 (17.5)

3.36 (2.04)

−

 HDL2, mg/dL

1.11 (0.88)

9.65 (3.42)

3.52 (1.23)

16.1 (5.78)

15.7 (6.76)

3.19 (1.68)

−

 HDL3, mg/dL

1.96 (0.87)

13.8 (3.68)

4.63 (1.09)

22.5 (5.81)

31.1 (7.09)

7.52 (2.39)

−

 HDL4, mg/dL

4.34 (1.17)

26.5 (5.16)

7.98 (1.51)

35.0 (5.57)

74.6 (10.8)

19.5 (4.72)

−